SEARCH

SEARCH BY CITATION

References

  • Al Dieri, R., Peyvandi, F., Santagostino, E., Giansily, M., Mannucci, P.M., Schved, J.F., Beguin, S. & Hemker, H.C. (2002) The thrombogram in rare inherited coagulation disorders: its relation to clinical bleeding. Thrombosis and Haemostasis, 88, 576582.
  • Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2004) Thrombin generation for the control of heparin treatment, comparison with the activated partial thromboplastin time. Journal of Thrombosis and Haemostasis, 2, 13951401.
  • Al Dieri, R., Alban, S., Beguin, S. & Hemker, H.C. (2006) Fixed dosage of low-molecular-weight heparins causes large individual variation in coagulability, only partly correlated to body weight. Journal of Thrombosis and Haemostasis, 4, 8389.
  • Allen, G.A., Hoffman, M., Roberts, H.R. & Monroe, D.M. (2006) Manipulation of prothrombin concentration improves response to high-dose factor VIIa in a cell-based model of haemophilia. British Journal of Haematology, 134, 314319.
  • Altman, R., Scazziota, A., Santoro, S. & Gonzalez, C. (2005) Abciximab does not inhibit the increase of thrombin generation produced in platelet-rich plasma in vitro by sodium arachidonate or tissue factor. Clinical and Applied Thrombosis/Hemostasis, 11, 271277.
  • Altman, R., Scazziota, A., De Lourdes, H.M. & Gonzalez, C. (2006) Recombinant factor VIIa reverses the inhibitory effect of aspirin or aspirin plus clopidogrel on in vitro thrombin generation. Journal of Thrombosis and Haemostasis, 4, 20222027.
  • Altman, R., Scazziota, A., Herrera, L. & Gonzalez, C. (2007) Relationship between thrombin generation and international normalized ratio in patients receiving oral vitamin K antagonist therapy. Journal of Thrombosis and Haemostasis, 5, 15521569.
  • Andresen, M.S., Abildgaard, U., Liestol, S., Sandset, P.M., Mowinckel, M.C., Odegaard, O.R., Larsen, M.L. & Diep, L.M. (2004) The ability of three global plasma assays to recognize thrombophilia. Thrombosis Research, 113, 411417.
  • Anzej, S., Bozic, M., Antovic, A., Peternel, P., Gaspersic, N., Rot, U., Tratar, G. & Stegnar, M. (2007) Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia. Thrombosis Research, 120, 3946.
  • Ardissino, D., Merlini, P.A., Bauer, K.A., Galvani, M., Ottani, F., Franchi, F., Bertocchi, F., Rosenberg, R.D. & Mannucci, P.M. (2003) Coagulation activation and long-term outcome in acute coronary syndromes. Blood, 102, 27312735.
  • Baglin, T. (2005) The measurement and application of thrombin generation. British Journal of Haematology, 130, 653661.
  • Baglin, T., Luddington, R., Brown, K. & Baglin, C. (2003) Incidence of recurrent venous thromboembolism in relation to clinical and thrombophilic risk factors: prospective cohort study. Lancet, 362, 523526.
  • Barber, M., Langhorne, P., Rumley, A., Lowe, G.D.O. & Stott, D.J. (2004) Hemostatic function and progressing ischemic stroke: D-dimer predicts early clinical progression. Stroke, 35, 14211425.
  • Barrowcliffe, T.W., Cattaneo, M., Podda, G.M., Bucciarelli, P., Lussana, F., Lecchi, A., Toh, C.H., Hemker, H.C., Beguin, S., Ingerslev, J. & Sorensen, B. (2006) New approaches for measuring coagulation. Haemophilia, 12(Suppl. 3), 7681.
  • Beguin, S., Kumar, R., Keularts, I., Seligsohn, U., Coller, B.S. & Hemker, H.C. (1999) Fibrin-dependent procoagulant activity requires Gp1b receptors and von Willebrand factor. Blood, 93, 564570.
  • Beguin, S., Keularts, I., Al Dieri, R., Bellucci, S., Caen, J. & Hemker, H.C. (2004) Fibrin polymerization is crucial for thrombin generation in platelet-rich plasma in a VWF-GPIb-dependent process, defective in Bernard-Soulier syndrome. Journal of Thrombosis and Haemostasis, 2, 170176.
  • Beltran-Miranda, C.P., Khan, A., Jaloma-Cruz, A.R. & Laffan, M.A. (2005) Thrombin generation and phenotypic correlation in haemophilia A. Haemophilia, 11, 326334.
  • Bijsterveld, N.R., Moons, A.H., Boekholdt, S.M., Van Aken, B.E., Fennema, H., Peters, R.J., Meijers, J.C., Buller, H.R. & Levi, M. (2002) Ability of recombinant factor VIIa to reverse the anticoagulant effect of the pentasaccharide fondaparinux in healthy volunteers. Circulation, 106, 25502554.
  • Butenas, S., Van’t Veer, C. & Mann, K.G. (1999) “Normal” thrombin generation. Blood, 94, 21692178.
  • Butenas, S., Brummel, K.E., Branda, R.F., Paradis, S.G. & Mann, K.G. (2002) Mechanism of factor VIIa-dependent coagulation in hemophilia blood. Blood, 99, 923930.
  • Castoldi, E., Simioni, P., Tormene, D., Thomassen, M.C., Spiezia, L., Gavasso, S. & Rosing, J. (2007) Differential effects of high prothrombin levels on thrombin generation depending on the cause of the hyperprothrombinemia. Journal of Thrombosis and Haemostasis, 5, 971979.
  • Cauwenberghs, S., Feijge, M.A., Theunissen, E., Heemskerk, J.W., Van Pampus, E.C. & Curvers, J. (2007) Novel methodology for assessment of prophylactic platelet transfusion therapy by measuring increased thrombus formation and thrombin generation. British Journal of Haematology, 136, 480490.
  • Chantarangkul, V., Clerici, M., Bressi, C., Giesen, P.L. & Tripodi, A. (2003) Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability. Haematologica, 88, 547554.
  • Chantarangkul, V., Clerici, M., Bressi, C. & Tripodi, A. (2004) Standardization of the endogenous thrombin potential measurement: how to minimize the effect of residual platelets in stored plasma. British Journal of Haematology, 124, 355357.
  • Christiansen, S.C., Cannegieter, S.C., Koster, T., Vandenbroucke, J.P. & Rosendaal, F.R. (2005) Thrombophilia, clinical factors, and recurrent venous thrombotic events. JAMA: The Journal of the American Medical Association, 293, 23522361.
  • Collins, P.W., Macchiavello, L.I., Lewis, S.J., Macartney, N.J., Saayman, A.G., Luddington, R., Baglin, T. & Findlay, G.P. (2006) Global tests of haemostasis in critically ill patients with severe sepsis syndrome compared to controls. British Journal of Haematology, 135, 220227.
  • Dargaud, Y., Beguin, S., Lienhart, A., Al Dieri, R., Trzeciak, C., Bordet, J.C., Hemker, H.C. & Negrier, C. (2005a) Evaluation of thrombin generating capacity in plasma from patients with haemophilia A and B. Thrombosis and Haemostasis, 93, 475480.
  • Dargaud, Y., Lienhart, A., Meunier, S., Hequet, O., Chavanne, H., Chamouard, V., Marin, S. & Negrier, C. (2005b) Major surgery in a severe haemophilia A patient with high titre inhibitor: use of the thrombin generation test in the therapeutic decision. Haemophilia, 11, 552558.
  • Dargaud, Y., Luddington, R. & Baglin, T.P. (2006a) Elimination of contact factor activation improves measurement of platelet-dependent thrombin generation by calibrated automated thrombography at low-concentration tissue factor. Journal of Thrombosis and Haemostasis, 4, 11601161.
  • Dargaud, Y., Bordet, J.C., Trzeciak, M.C., Vinciguerra, C. & Negrier, C. (2006b) A case of Glanzmann’s thrombasthenia successfully treated with recombinant factor viia during a surgical procedure: observations on the monitoring and the mechanism of action of this drug. Haematologica, 91; 6 Suppl., ECR20.
  • Dargaud, Y., Trzeciak, M.C., Bordet, J.C., Ninet, J. & Negrier, C. (2006c) Use of calibrated automated thrombinography ± thrombomodulin to recognise the prothrombotic phenotype. Thrombosis and Haemostasis, 96, 562567.
  • Dargaud, Y., Luddington, R., Gray, E., Negrier, C., Lecompte, T., Petros, S., Hogwood, J., Bordet, J.C., Regnault, V., Siegemund, A. & Baglin, T. (2007) Effect of standardization and normalization on imprecision of calibrated automated thrombography: an international multicentre study. British Journal of Haematology, 139, 303309.
  • Dielis, A.W.J.H., Castoldi, E., Spronk, H., Van Oerle, R., Hamulyak, K., Ten Cate, H. & Rosing, J. (2008) Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. Journal of Thrombosis and Haemostasis, 6, 125131.
  • Eilertsen, A.L., Liestol, S., Mowinckel, M.C., Hemker, H.C. & Sandset, P.M. (2007) Differential impact of conventional and low-dose oral hormone therapy (HT), tibolone and raloxifene on functionality of the activated protein C system. Thrombosis and Haemostasis, 97, 938943.
  • Elmas, E., Kaelsch, T., Wolpert, C., Sueselbeck, T., Bertsch, T., Dempfle, C.E. & Borggrefe, M. (2006) Assessment of markers of thrombin generation in patients with acute myocardial infarction complicated by ventricular fibrillation. Clinical Cardiology, 29, 165169.
  • Esmon, C.T. (1989) The roles of protein C and thrombomodulin in the regulation of blood coagulation. Journal of Biological Chemistry, 264, 47434746.
  • Esmon, N.L., Smirnov, M.D., Safa, O. & Esmon, C.T. (1999) Lupus anticoagulants, thrombosis and the protein C system. Haematologica, 84, 446451.
  • Evans, G., Luddington, R. & Baglin, T. (2001) Beriplex P/N reverses severe warfarin-induced overanticoagulation immediately and completely in patients presenting with major bleeding. British Journal of Haematology, 115, 9981001.
  • Faber, C.G., Lodder, J., Kessels, F. & Troost, J. (2003) Thrombin generation in platelet-rich plasma as a tool for the detection of hypercoagulability in young stroke patients. Pathophysiology of Haemostasis and Thrombosis, 33, 5258.
  • Furie, K.L., Rosenberg, R., Thompson, J.L., Bauer, K., Mohr, J.P., Rosner, B., Sciacca, R., Barzegar, S., Thornell, B., Costigan, T. & Kistler, J.P. (2004) Thrombin generation in non-cardioembolic stroke subtypes: the Hemostatic System Activation Study [see comment]. Neurology, 63, 777784.
  • Gailani, D. & Broze, Jr, G.J. (1991) Factor XI activation in a revised model of blood coagulation. Science, 253, 909912.
  • Gatt, A., Van Veen, J., Cooper, P., Kitchen, S. & Makris, M. (2006) Reversal of anticoagulation as assessed by thrombin generation measurement. Blood (ASH Annual Meeting Abstracts), 108, 876.
  • Gatt, A., Van Veen, J.J., Cooper, P., Kitchen, S. & Makris, M. (2007a) Protein C deficiency screening using a thrombin generation assay - an upgrade. Thrombosis and Haemostasis, 98, 691692.
  • Gatt, A., Van Veen, J.J., Bowyer, A., Cooper, P.C., Kitchen, S. & Makris, M. (2007b) Significant variation in thrombin generation potential in “adequately” anticoagulated patients. http://itinerary.abstractsondemand.com, XXIst congress of the international society on haemostasis and thrombosis, Geneva, Switzerland, P-M-097.
  • Gerotziafas, G.T., Zervas, K., Arzoglou, P., Karavaggeli, E., Parashou, S., Van Dreden, P., Christakis, J. & Samama, M.M. (2002) On the mechanism of action of recombinant activated factor VII administered to patients with severe thrombocytopenia and life-threatening haemorrhage: focus on prothrombin activation. British Journal of Haematology, 117, 705708.
  • Gerotziafas, G.T., Chakroun, T., Depasse, F., Arzoglou, P., Samama, M.M. & Elalamy, I. (2004a) The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formation. Thrombosis and Haemostasis, 91, 977985.
  • Gerotziafas, G.T., Depasse, F., Chakroun, T., Samama, M.M. & Elalamy, I. (2004b) Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole blood. Thrombosis and Haemostasis, 91, 531537.
  • Gerotziafas, G.T., Depasse, F., Chakroun, T., Van Dreden, P., Samama, M.M. & Elalamy, I. (2004c) Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasma. Blood Coagulation & Fibrinolysis, 15, 149156.
  • Gerotziafas, G.T., Depasse, F., Busson, J., Leflem, L., Elalamy, I. & Samama, M.M. (2005) Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assay. Thrombosis Journal, 3, 16.
  • Gerotziafas, G.T., Petropoulou, A.D., Verdy, E., Samama, M.M. & Elalamy, I. (2007a) Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation. Journal of Thrombosis and Haemostasis, 5, 955962.
  • Gerotziafas, G.T., Elalamy, I., Depasse, F., Perzborn, E. & Samama, M.M. (2007b) In vitro inhibition of thrombin generation, after tissue factor pathway activation, by the oral, direct factor Xa inhibitor rivaroxaban. Journal of Thrombosis and Haemostasis, 5, 886888.
  • Hackeng, T.M., Sere, K.M., Tans, G. & Rosing, J. (2006) Protein S stimulates inhibition of the tissue factor pathway by tissue factor pathway inhibitor. Proceedings of the National Academy of Sciences of the United States of America, 103, 31063111.
  • Hemker, H.C. & Beguin, S. (1995) Thrombin generation in plasma: its assessment via the endogenous thrombin potential. Thrombosis and Haemostasis, 74, 134138.
  • Hemker, H.C., Willems, G.M. & Beguin, S. (1986) A computer assisted method to obtain the prothrombin activation velocity in whole plasma independent of thrombin decay processes. Thrombosis and Haemostasis, 56, 917.
  • Hemker, H.C., Wielders, S., Kessels, H. & Beguin, S. (1993) Continuous registration of thrombin generation in plasma, its use for the determination of the thrombin potential. Thrombosis and Haemostasis, 70, 617624.
  • Hemker, H.C., Giesen, P.L., Ramjee, M., Wagenvoord, R. & Beguin, S. (2000) The thrombogram: monitoring thrombin generation in platelet-rich plasma. Thrombosis and Haemostasis, 83, 589591.
  • Hemker, H.C., Giesen, P., Al Dieri, R., Regnault, V., De Smedt, E., Wagenvoord, R., Lecompte, T. & Beguin, S. (2003) Calibrated automated thrombin generation measurement in clotting plasma. Pathophysiology of Haemostasis and Thrombosis, 33, 415.
  • Hezard, N., Bouaziz-Borgi, L., Remy, M.G. & Nguyen, P. (2006) Utility of thrombin-generation assay in the screening of factor V G1691A (Leiden) and prothrombin G20210A mutations and protein S deficiency. Clinical Chemistry, 52, 665670.
  • Hezard, N., Bouaziz-Borgi, L., Remy, M.G., Florent, B. & Nguyen, P. (2007) Protein C deficiency screening using a thrombin-generation assay. Thrombosis and Haemostasis, 97, 165166.
  • Hoffman, M. & Monroe, III, D.M. (2001) A cell-based model of hemostasis. Thrombosis and Haemostasis, 85, 958965.
  • Hron, G., Kollars, M., Binder, B.R., Eichinger, S. & Kyrle, P.A. (2006) Identification of patients at low risk for recurrent venous thromboembolism by measuring thrombin generation. JAMA: The Journal of the American Medical Association, 296, 397402.
  • Huvers, F., Slappendel, R., Benraad, B., Van Hellemondt, G. & Van Kraaij, M. (2005) Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid. Netherlands Journal of Medicine, 63, 184186.
  • Van Hylckama Vlieg, A., Christiansen, S.C., Luddington, R., Cannegieter, S.C., Rosendaal, F.R. & Baglin, T.P. (2007) Elevated endogenous thrombin potential is associated with an increased risk of a first deep venous thrombosis but not with the risk of recurrence. British Journal of Haematology, 138, 769774.
  • Jackson, C.M., Esnouf, M.P. & Lindahl, T.L. (2003) A critical evaluation of the prothrombin time for monitoring oral anticoagulant therapy. Pathophysiology of Haemostasis and Thrombosis, 33, 4351.
  • Keularts, I.M., Hamulyak, K., Hemker, H.C. & Beguin, S. (2000) The effect of DDAVP infusion on thrombin generation in platelet-rich plasma of von Willebrand type 1 and in mild haemophilia A patients. Thrombosis and Haemostasis, 84, 638642.
  • Keularts, I.M., Zivelin, A., Seligsohn, U., Hemker, H.C. & Beguin, S. (2001) The role of factor XI in thrombin generation induced by low concentrations of tissue factor. Thrombosis and Haemostasis, 85, 10601065.
  • Kjalke, M., Ezban, M., Monroe, D.M., Hoffman, M., Roberts, H.R. & Hedner, U. (2001) High-dose factor VIIa increases initial thrombin generation and mediates faster platelet activation in thrombocytopenia-like conditions in a cell-based model system. British Journal of Haematology, 114, 114120.
  • Lawson, J.H., Butenas, S., Ribarik, N. & Mann, K.G. (1993) Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. Journal of Biological Chemistry, 268, 767770.
  • Lecompte, T., Wahl, D., Perret-Guillaume, C., Hemker, H.C., Lacolley, P. & Regnault, V. (2007) Hypercoagulability resulting from opposite effects of lupus anticoagulants is associated strongly with thrombotic risk. Haematologica, 92, 714715.
  • Lewis, S.J., Stephens, E., Florou, G., Macartney, N.J., Hathaway, L.S., Knipping, J. & Collins, P.W. (2007) Measurement of global haemostasis in severe haemophilia A following factor VIII infusion. British Journal of Haematology, 138, 775782.
  • Liestol, S., Sandset, P.M., Mowinckel, M.C. & Wisloff, F. (2007) Activated protein C resistance determined with a thrombin generation-based test is associated with thrombotic events in patients with lupus anticoagulants. Journal of Thrombosis and Haemostasis, 5, 22042211.
  • Livnat, T., Zivelin, A., Martinowitz, U., Salomon, O. & Seligsohn, U. (2006) Prerequisites for recombinant factor VIIa-induced thrombin generation in plasmas deficient in factors VIII, IX or XI. Journal of Thrombosis and Haemostasis, 4, 192200.
  • Luddington, R.J. (2005) Thrombelastography/thromboelastometry [Review] [87 refs]. Clinical & Laboratory Haematology, 27, 8190.
  • Luddington, R. & Baglin, T. (2004) Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition. Journal of Thrombosis and Haemostasis, 2, 19541959.
  • Macfarlane, R. & Biggs, R. (1953) A thrombin generation test; the application in haemophilia and thrombocytopenia. Journal of Clinical Pathology, 6, 38.
  • Makris, M., Greaves, M., Phillips, W.S., Kitchen, S., Rosendaal, F.R. & Preston, E.F. (1997) Emergency oral anticoagulant reversal: the relative efficacy of infusions of fresh frozen plasma and clotting factor concentrate on correction of the coagulopathy. Thrombosis and Haemostasis, 77, 477480.
  • Male, C., Mitchell, L., Julian, J., Vegh, P., Joshua, P., Adams, M., David, M. & Andrew, M.E. (2001) Acquired activated protein C resistance is associated with lupus anticoagulants and thrombotic events in pediatric patients with systemic lupus erythematosus. Blood, 97, 844849.
  • McIntosh, J.H., Owens, D., Lee, C.A., Raut, S. & Barrowcliffe, T.W. (2003) A modified thrombin generation test for the measurement of factor VIII concentrates. Journal of Thrombosis and Haemostasis, 1, 10051011.
  • Monroe, D.M., Hoffman, M., Oliver, J.A. & Roberts, H.R. (1997) Platelet activity of high-dose factor VIIa is independent of tissue factor. British Journal of Haematology, 99, 542547.
  • Paramo, J.A., Orbe, J., Beloqui, O., Benito, A., Colina, I., Martinez-Vila, E. & Diez, J. (2004) Prothrombin fragment 1+2 is associated with carotid intima-media thickness in subjects free of clinical cardiovascular disease. Stroke, 35, 10851089.
  • Pitney, W.R. & Dacie, J.V. (1953) A simple method of studying the generation of thrombin in recalcified plasma; application in the investigation of haemophilia. Journal of Clinical Pathology, 6, 914.
  • Ramjee, M.K. (2000) The use of fluorogenic substrates to monitor thrombin generation for the analysis of plasma and whole blood coagulation. Analytical Biochemistry, 277, 1118.
  • Rand, M.D., Lock, J.B., Van’t Veer, C., Gaffney, D.P. & Mann, K.G. (1996) Blood clotting in minimally altered whole blood. Blood, 88, 34323445.
  • Rapaport, S.I. (1991) The extrinsic pathway inhibitor: a regulator of tissue factor dependent blood coagulation. Thrombosis and Haemostasis, 66, 615.
  • Regnault, V., Beguin, S. & Lecompte, T. (2003a) Calibrated automated thrombin generationin frozen-thawed platelet-rich plasma to detect hypercoagulability. Pathophysiology of Haemostasis and Thrombosis, 33, 2329.
  • Regnault, V., Beguin, S., Wahl, D., De Maistre, E., Coenraad, H.H. & Lecompte, T. (2003b) Thrombinography shows acquired resistance to activated protein C in patients with lupus anticoagulants. Thrombosis and Haemostasis, 89, 208212.
  • Regnault, V., Hemker, H.C., Wahl, D. & Lecompte, T. (2004) Phenotyping the haemostatic system by thrombography--potential for the estimation of thrombotic risk. Thrombosis Research, 114, 539545.
  • Regnault, V., Boehlen, F., Ozsahin, H., Wahl, D., De Groot, P.G., Lecompte, T. & De Moerloose, P. (2005) Anti-protein S antibodies following a varicella infection: detection, characterization and influence on thrombin generation. Journal of Thrombosis and Haemostasis, 3, 12431249.
  • Reverter, J.C., Beguin, S., Kessels, H., Kumar, R., Hemker, H.C. & Coller, B.S. (1996) Inhibition of platelet-mediated, tissue factor-induced thrombin generation by the mouse/human chimeric 7e3 antibody. Potential implications for the effect of c7E3 Fab treatment on acute thrombosis and ``clinical restenosis’’. Journal of Clinical Investigation, 98, 863874.
  • Rugeri, L., Beguin, S., Hemker, C., Bordet, J.C., Fleury, R., Chatard, B., Negrier, C. & Dargaud, Y. (2007) Thrombin-generating capacity in patients with von Willebrand’s disease. Haematologica, 92, 16391646.
  • Sere, K.M., Rosing, J., Hackeng, T.M., Sere, K.M., Rosing, J. & Hackeng, T.M. (2004) Inhibition of thrombin generation by protein S at low procoagulant stimuli: implications for maintenance of the hemostatic balance [see comment]. Blood, 104, 36243630.
  • Siegemund, T., Petros, S., Siegemund, A., Scholz, U. & Engelmann, L. (2003) Thrombin generation in severe haemophilia A and B: the endogenous thrombin potential in platelet-rich plasma. Thrombosis and Haemostasis, 90, 781786.
  • Siegemund, A., Petros, S., Siegemund, T., Scholz, U., Seyfarth, H.J., Engelmann, L., Siegemund, A., Petros, S., Siegemund, T., Scholz, U., Seyfarth, H.J. & Engelmann, L. (2004) The endogenous thrombin potential and high levels of coagulation factor VIII, factor IX and factor XI. Blood Coagulation & Fibrinolysis, 15, 241244.
  • De Smedt, E., Al Dieri, R., Spronk, H., Hamulyak, K. & Ten Cate, H. (2007) The necessity of continuous individual calibration in continuous fluorogenic measurement of the thrombin generation curve. http://itinerary.abstractsondemand.com, XXIst congress of the international society on haemostasis and thrombosis, Geneva, Switzerland, P-M-094.
  • Sorensen, B. & Ingerslev, J. (2004) Whole blood clot formation phenotypes in hemophilia A and rare coagulation disorders. Patterns of response to recombinant factor VIIa. Journal of Thrombosis and Haemostasis, 2, 102110.
  • Sorensen, B., Johansen, P., Christiansen, K., Woelke, M. & Ingerslev, J. (2003) Whole blood coagulation thrombelastographic profiles employing minimal tissue factor activation. Journal of Thrombosis and Haemostasis, 1, 551558.
  • Stief, T.W. (2007) Inhibition of thrombin generation in recalcified plasma. Blood Coagulation & Fibrinolysis, 18, 751760.
  • Tanaka, K.A., Szlam, F., Katori, N., Sato, N., Vega, J.D. & Levy, J.H. (2004) The effects of argatroban on thrombin generation and hemostatic activation in vitro. Anesthesia and Analgesia, 99, 12831289.
  • Tanaka, K.A., Szlam, F., Sun, H.Y., Taketomi, T. & Levy, J.H. (2007a) Thrombin generation assay and viscoelastic coagulation monitors demonstrate differences in the mode of thrombin inhibition between unfractionated heparin and bivalirudin. Anesthesia and Analgesia, 105, 933939, table.
  • Tanaka, K.A., Szlam, F., Dickneite, G. & Levy, J.H. (2007b) Effects of prothrombin complex concentrate and recombinant activated factor VII on vitamin K antagonist induced anticoagulation. Thrombosis Research, 122, 117123.
  • Tanne, D., Macko, R.F., Lin, Y., Tilley, B.C., Levine, S.R. & NINDS rtPA Stroke Study Group (2006) Hemostatic activation and outcome after recombinant tissue plasminogen activator therapy for acute ischemic stroke. Stroke, 37, 17981804.
  • Tappenden, K.A., Gallimore, M.J., Evans, G., Mackie, I.J. & Jones, D.W. (2007) Thrombin generation: a comparison of assays using platelet-poor and -rich plasma and whole blood samples from healthy controls and patients with a history of venous thromboembolism. British Journal of Haematology, 139, 106112.
  • Tchaikovski, S.N., Van Vliet, H.A., Christella, M., Thomassen, L.G., Bertina, R.M., Rosendaal, F.R., Sandset, P.M., Helmerhorst, F.M., Tans, G. & Rosing, J. (2007) Effect of oral contraceptives on thrombin generation measured via calibrated automated thrombography. Thrombosis and Haemostasis, 98, 13501356.
  • Tripodi, A., Primignani, M., Chantarangkul, V., Clerici, M., Dell’Era, A., Fabris, F., Salerno, F. & Mannucci, P.M. (2006) Thrombin generation in patients with cirrhosis: the role of platelets. Hepatology, 44, 440445.
  • Turecek, P.L., Varadi, K., Keil, B., Negrier, C., Berntorp, E., Astermark, J., Bordet, J.C., Morfini, M., Linari, S. & Schwarz, H.P. (2003) Factor VIII inhibitor-bypassing agents act by inducing thrombin generation and can be monitored by a thrombin generation assay. Pathophysiology of Haemostasis and Thrombosis, 33, 1622.
  • Vanschoonbeek, K., Feijge, M.A., Van Kampen, R.J., Kenis, H., Hemker, H.C., Giesen, P.L. & Heemskerk, J.W. (2004) Initiating and potentiating role of platelets in tissue factor-induced thrombin generation in the presence of plasma: subject-dependent variation in thrombogram characteristics. Journal of Thrombosis and Haemostasis, 2, 476484.
  • Varadi, K., Negrier, C., Berntorp, E., Astermark, J., Bordet, J.C., Morfini, M., Linari, S., Schwarz, H.P. & Turecek, P.L. (2003) Monitoring the bioavailability of FEIBA with a thrombin generation assay. Journal of Thrombosis and Haemostasis, 1, 23742380.
  • Van Veen, J.J., Gatt, A., Cooper, P.C., Kitchen, S. & Makris, M. (2006) Between-batch variation of calibrator activity can significantly influence fluorogenic measurement of thrombin generation. Journal of Thrombosis and Haemostasis, 4, 25142516.
  • Van Veen, J.J., Gatt, A., Cooper, P.C., Kitchen, S., Bowyer, A.E. & Makris, M. (2008a) Corn trypsin inhibitor in fluorogenic thrombin generation measurements is only necessary at low tissue factor concentrations and influences the relationship between FVIII:C and thrombogram parameters. Blood Coagulation & Fibrinolysis, 19, 183189.
  • Van Veen, J.J., Gatt, A., Bowyer, A.E., Cooper, P.C., Kitchen, S. & Makris, M. (2008b) The effect of tissue factor concentration on calibrated automated thrombography in the presence of inhibitor bypass agents. International Journal of Laboratory Hematology, doi:DOI: 10.1111/j.1751-553X.2007.01022.x.
  • Walker, F.J. & Fay, P.J. (1992) Regulation of blood coagulationby the protein C system. FASEB Journal, 6, 25612567.
  • Wegert, W., Harder, S., Bassus, S. & Kirchmaier, C.M. (2005) Platelet-dependent thrombin generation assay for monitoring the efficacy of recombinant Factor VIIa. Platelets, 16, 4550.
  • Wienen, W., Stassen, J.M., Priepke, H., Ries, U.J. & Hauel, N. (2007) In-vitro profile and ex-vivo anticoagulant activity of the direct thrombin inhibitor dabigatran and its orally active prodrug, dabigatran etexilate. Thrombosis and Haemostasis, 98, 155162.